A case series of serious and unexpected adverse drug reactions under treatment with cariprazine

被引:3
|
作者
Heck, Johannes [1 ]
Seifert, Johanna [2 ]
Stichtenoth, Dirk O. [1 ,3 ]
Schroeder, Christoph [1 ,4 ]
Groh, Adrian [2 ]
Szycik, Gregor R. [2 ]
Degner, Detlef [5 ]
Adamovic, Ivana [5 ]
Schneider, Michael [6 ]
Glocker, Catherine [7 ]
Ruther, Eckart [7 ,8 ]
Bleich, Stefan [2 ]
Grohmann, Renate [7 ]
Toto, Sermin [2 ]
机构
[1] Hannover Med Sch, Inst Clin Pharmacol, Carl Neuberg Str 1, D-30625 Hannover, Germany
[2] Hannover Med Sch, Dept Psychiat Social Psychiat & Psychotherapy, Hannover, Germany
[3] Hannover Med Sch, Hannover, Germany
[4] Hannover Med Sch, Pharmacovigilance, Hannover, Germany
[5] Georg August Univ Gottingen, Dept Psychiat & Psychotherapy, Gottingen, Germany
[6] Univ Clin Psychiat & Psychotherapy, Brandenburg Med Sch, Immanuel Klin, Rudersdorf, Germany
[7] Ludwig Maximilian Univ Munich, Dept Psychiat & Psychotherapy, Munich, Germany
[8] Prosomno Klin & Poliklin Schlafmed, Munich, Germany
来源
CLINICAL CASE REPORTS | 2021年 / 9卷 / 05期
关键词
adverse drug reactions; cariprazine; dopamine supersensitivity psychosis; drug safety; hyperprolactinemia;
D O I
10.1002/ccr3.4084
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Reporting of new or unexpected adverse drug reactions of medicines that are subject to additional monitoring ("black triangle" label), such as the antipsychotic drug cariprazine, is of paramount importance to improve pharmacotherapy safety.
引用
收藏
页数:8
相关论文
共 50 条